A new scoring system for a form of leukemia known as myelodysplastic syndrome identifies patients who appear to have low-risk disease but actually have poor prospects of survival. Physicians tend to adopt a watch and wait approach to low-risk MDS patients, which the researcher says misses low-risk/poor prognosis patients.
More...